CVS Health Corporation (CVS) is Delaney Dennis R’s 9th Largest Position

Delaney Dennis R reduced its position in CVS Health Corporation (NYSE:CVS) by 3.7% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 22,490 shares of the pharmacy operator’s stock after selling 862 shares during the period. CVS Health Corporation comprises approximately 3.7% of Delaney Dennis R’s holdings, making the stock its 9th biggest holding. Delaney Dennis R’s holdings in CVS Health Corporation were worth $1,766,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Keel Point LLC grew its stake in CVS Health Corporation by 0.7% in the 1st quarter. Keel Point LLC now owns 3,296 shares of the pharmacy operator’s stock worth $259,000 after acquiring an additional 22 shares during the period. Proffitt & Goodson Inc. grew its stake in CVS Health Corporation by 0.4% in the 1st quarter. Proffitt & Goodson Inc. now owns 15,782 shares of the pharmacy operator’s stock worth $1,239,000 after acquiring an additional 65 shares during the period. Oxbow Advisors LLC grew its stake in CVS Health Corporation by 0.8% in the 1st quarter. Oxbow Advisors LLC now owns 12,090 shares of the pharmacy operator’s stock worth $949,000 after acquiring an additional 90 shares during the period. Dumont & Blake Investment Advisors LLC grew its stake in CVS Health Corporation by 0.6% in the 1st quarter. Dumont & Blake Investment Advisors LLC now owns 16,122 shares of the pharmacy operator’s stock worth $1,266,000 after acquiring an additional 90 shares during the period. Finally, Cue Financial Group Inc. grew its stake in CVS Health Corporation by 3.6% in the 1st quarter. Cue Financial Group Inc. now owns 2,708 shares of the pharmacy operator’s stock worth $213,000 after acquiring an additional 95 shares during the period. 81.55% of the stock is owned by hedge funds and other institutional investors.

Several analysts have recently issued reports on the stock. Cowen and Company reissued an “outperform” rating and set a $86.00 price objective on shares of CVS Health Corporation in a research note on Tuesday, June 13th. BidaskClub raised shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, August 2nd. Citigroup Inc. lowered their price objective on shares of CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating for the company in a research note on Thursday, August 17th. Leerink Swann set a $90.00 price objective on shares of CVS Health Corporation and gave the company a “buy” rating in a research note on Tuesday, June 27th. Finally, Wolfe Research cut shares of CVS Health Corporation from an “outperform” rating to a “market perform” rating and lowered their price objective for the company from $89.00 to $82.00 in a research note on Monday, August 14th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $90.83.

Shares of CVS Health Corporation (NYSE CVS) traded up 2.61% during trading on Tuesday, reaching $81.80. 2,760,008 shares of the company’s stock were exchanged. The company has a 50 day moving average of $78.37 and a 200 day moving average of $78.89. The firm has a market capitalization of $83.15 billion, a P/E ratio of 16.29 and a beta of 0.92. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $91.82.

CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The business had revenue of $45.69 billion for the quarter, compared to analyst estimates of $45.36 billion. During the same period last year, the business posted $1.32 EPS. CVS Health Corporation’s revenue was up 4.5% compared to the same quarter last year. Equities analysts anticipate that CVS Health Corporation will post $5.88 earnings per share for the current fiscal year.

In related news, Director Richard J. Swift sold 2,500 shares of the firm’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $79.62, for a total value of $199,050.00. Following the transaction, the director now directly owns 3,258 shares in the company, valued at approximately $259,401.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Helena Foulkes sold 20,333 shares of the firm’s stock in a transaction on Monday, June 26th. The shares were sold at an average price of $80.00, for a total transaction of $1,626,640.00. Following the completion of the transaction, the executive vice president now owns 59,301 shares in the company, valued at $4,744,080. The disclosure for this sale can be found here. Insiders sold a total of 43,165 shares of company stock worth $3,390,847 over the last quarter. 0.61% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION WARNING: “CVS Health Corporation (CVS) is Delaney Dennis R’s 9th Largest Position” was first posted by Stock Observer and is owned by of Stock Observer. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.thestockobserver.com/2017/09/12/cvs-health-corporation-cvs-is-delaney-dennis-rs-9th-largest-position.html.

CVS Health Corporation Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply